Our previous study showed that selective TG2 inhibition reduced the spheroid forming capacity of SW620 colorectal cells [18], with similar observations made in ovarian [11], breast [30] and squamous carcinomas [11, 12, 22]. The gene discussed is TGM2; the disease is squamous cell carcinoma.